Magnetar Financial LLC 13D and 13G filings for Ibere Pharmaceuticals:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-02 11:10 am Sale | 2022-12-31 | 13G | Ibere Pharmaceuticals IBER | Magnetar Financial LLC | 785,872 5.690% | -7,419 (-0.94%) | Filing |
| 2022-01-14 1:43 pm Purchase | 2021-12-31 | 13G | Ibere Pharmaceuticals IBER | Magnetar Financial LLC | 793,291 5.750% | 793,291 (New Position) | Filing |